0.83 | 1.02%
| Price and Volume | |
|---|---|
| Recent Price | 81.76 |
| 52 Week High | 90.42 |
| 52 Week Low | 59.14 |
| Avg. Daily Vol. (Mil) | 0.90 |
| Beta (3 year) | 0.53 |
| Share Related Items | |
| Mkt Cap (Mil) | 7,685.44 |
| Shares Out (Mil) | 94.00 |
| Float (Mil) | 93.65 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 1.60 |
| Current Ratio | 1.90 |
| LT Debt/ Equity | 1.94 |
| Total Debt / Equity | 1.97 |
| Valuation Ratios | |
| Price Earnings | 14.90 |
| Price/Sales | 1.06 |
| Price/Book | 3.38 |
| Price/Cash Flow | 8.70 |
| Per Share Data | |
| Earnings | 5.50 |
| Sales | 77.11 |
| Book Value | 24.20 |
| Cash Flow | 9.41 |
| Business Summary | |
|---|---|
| Davita, Inc. operates kidney dialysis centers and provides related lab services mainly in dialysis centers and in contracted hospitals across the United States. It also operates other ancillary services and strategic initiatives. | |
| General Information | |
| 1551 Wewatta Street
Denver, CO 90503-5517 |
|
| www.davita.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 41000 | |
| CEO: Kent J. Thiry | |
| Short Interest | |
| Current Month (Mil) | 2.30 |
| Previous Month (Mil) | 1.90 |
| Short Interest Ratio (Days) | 2.70 |
| Management Effectiveness | |
| Return on Equity | 26.50 |
| Return on Assets | 6.60 |
| Return on Investments | 9.00 |
| Profitability | |
| Gross Margin | 33.30 |
| EBIT Margin | 16.80 |
| Profit Margin | 8.30 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,555.86 | 1,329.21 | 2,862.50 | 17.31 |
Oil *
106.66
|
|
UP
101.03 |
UP
11.39 |
UP
24.97 |
DOWN
0.14 |
10 Yr
1.73%
SPDR Gold
150.76
|
|
+0.81%
|
+0.86%
|
+0.88%
|
-0.80%
|
Data delayed 20 minutes |
Connect with TheStreet